Zhen Cao

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation”.

Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation

Cancer Cell(2020)10.1016/j.ccell.2020.03.001

N/A

3.8DataRank · unranked

166 citations

Chuanli Zhou, Xiaoling Li, Spencer Barnes, Su Deng, Elizabeth Hoover +27 more

Lineage Reversion Drives WNT Independence in Intestinal Cancer

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1536

N/A

2.6DataRank · unranked

84 citations

Sukanya Goswami, Yang Hu, Fanying Tang, María Paz Zafra, Charles J. Murphy +9 more

Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer Metastasis

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1242

N/A

1.5DataRank · unranked

61 citations

Marcus Ruscetti, Zhen Cao, Yu-Jui Ho, Timour Baslan, Min Zou +20 more

Lineage reversion drives WNT independence in intestinal cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.01.22.914689

N/A

0DataRank · unranked

12 citations

Sukanya Goswami, Yang Hu, Fanying Tang, María Paz Zafra, Charles J. Murphy +8 more

Lysosome‐dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer

Molecular Oncology(2023)10.1002/1878-0261.13497

N/A

0DataRank · unranked

13 citations

Guoliang Li, Lindsay J. Celada, Wenfu Lu, Thanigaivelan Kanagasabai, Weiran Feng +13 more